Price $9.70 |
Market Cap
1.67B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.56
|
Dividend %
-
|
|
P/CF
5.0
|
P/FCF
5.8
|
Op. Cash Flow
340.1K
|
FCF
1.2
|
|
Op. Margin
-20.30%
|
Net Margin
-37.80%
|
ROE
-
|
ROI
-9.10%
|
|
ROA
-10.10%
|
EPS Growth
77.90%
|
Current Ratio
1.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Allergan plc (AGN) | $160.22 | - | 2.20% | 44.79B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.54 | - | - | 66.1M | Strong Buy |
| Integer Holdings Corp (ITGR) | $80.67 | - | - | 2.46B | Strong Buy |
| Bausch Health Companies Inc (BHC) | $23.09 | - | - | 6.58B | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.42 | - | - | 13.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
